news, research, sleep disorders CEO of Napping news, research, sleep disorders CEO of Napping

National Sleep Foundation Research Reveals Nearly 1/3 of Americans Diagnosed with Sleep Apnea are Not Receiving Treatment Despite Health Risks

A new National Sleep Foundation study finds 31% of diagnosed sleep apnea patients aren’t receiving treatment, despite serious health risks. The research highlights major gaps in awareness, diagnosis, and available therapies. With millions at risk, NSF and Inspire Medical Systems aim to improve education and access to care. Learn more about the findings and sleep apnea solutions today.

Read More
news, tech, sleep disorders CEO of Napping news, tech, sleep disorders CEO of Napping

Neurovalens Expands Access to Modius Sleep for Veterans Through U.S. Department of Veterans Affairs (VA) Program

Veterans struggling with chronic insomnia can now access Neurovalens' FDA-cleared Modius Sleep device through the VA program. This drug-free neurostimulation technology helps improve sleep quality, offering a noninvasive solution for those affected. Learn how this innovative treatment is transforming veteran sleep health.

Read More
news, tech, sleep disorders CEO of Napping news, tech, sleep disorders CEO of Napping

Wesper Revolutionizes GLP-1 Sleep Apnea Screening and Enables Personalized Treatment

Wesper is transforming obesity and sleep apnea care with advanced home sleep apnea testing (HSAT) and GLP-1 therapy integration. A recent study highlights the impact of BMI, age, and gender on apnea severity, revealing higher risks for men and obese patients. With AI-powered insights and a 95% PSG correlation, Wesper helps providers deliver personalized, effective care for better sleep and metabolic health.

Read More
tech, news, sleep disorders CEO of Napping tech, news, sleep disorders CEO of Napping

Huxley Medical Announces FDA Clearance for Cellular-Enabled SANSA Home Sleep Apnea Test

Huxley Medical's SANSA home sleep apnea test now has FDA clearance for cellular data upload, eliminating the need for Bluetooth pairing or apps. This innovation simplifies home testing, improves accuracy, and accelerates diagnoses for sleep physicians. SANSA’s AI-powered, chest-worn patch enhances sleep apnea detection with real-time data transfer. Learn more about this breakthrough in sleep health.

Read More
news, tech, partnership, sleep disorders CEO of Napping news, tech, partnership, sleep disorders CEO of Napping

Happy Sleep Partners with Dentulu to Revolutionize Sleep Apnea Care Nationwide

Happy Sleep partners with Dentulu to offer a groundbreaking, at-home sleep apnea diagnosis and treatment solution. The collaboration provides accessible, FDA-approved sleep tests, custom oral appliances, and ongoing care, all covered by most insurance providers. With a focus on convenience and personalized care, this partnership aims to improve sleep health for millions of Americans.

Read More
news, sleep disorders CEO of Napping news, sleep disorders CEO of Napping

Sleep Consortium Announces the Illuminate Hypersomnia Adjunct Scientific Meeting to Tackle Drug Development Challenges for Idiopathic Hypersomnia

Join the Illuminate Hypersomnia Adjunct Scientific Meeting on February 13, 2025, to address critical drug development challenges for idiopathic hypersomnia (IH). This virtual event will focus on overcoming key hurdles in treatment, featuring expert discussions on brain fog, research barriers, and patient-centered solutions.

Read More
news, tech, sleep disorders CEO of Napping news, tech, sleep disorders CEO of Napping

Modius Sleep FDA-Cleared Non-Invasive Device that Treats Chronic Insomnia is Now Available for Purchase

Neurovalens introduces Modius Sleep, an FDA-cleared, non-invasive device designed to treat chronic insomnia. Using safe electrical pulses to stimulate the vestibular nerve, it influences circadian rhythm and sleep patterns, offering a drug-free solution. Available with a physician's prescription, Modius Sleep helps users fall asleep faster and stay asleep longer.

Read More